Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure

Matrix metalloproteinase-1 and -2 levels are differently regulated in acute exacerbation of heart failure in patients with and without left ventricular systolic dysfunction

(2009) Yoshiro Naito et al.   HEART AND VESSELS

Interleukin-6 Released from Fibroblasts Is Essential for Up-regulation of Matrix Metalloproteinase-1 Expression by U937 Macrophages in Coculture

(2009) Kamala P. Sundararaj et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inflammatory Mediators in Chinese Patients With Congestive Heart Failure

(2009) Yongqing Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Tumor Necrosis Factor-α and Mortality in Heart Failure

(2008) Shannon M. Dunlay et al.   CIRCULATION

INFLUENCE OF BLOOD SAMPLING PROCEDURE ON PLASMA CONCENTRATIONS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS

(2008) Patrick Rossignol et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Circulating Stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction

(2008) D. Kelly et al.   EUROPEAN JOURNAL OF HEART FAILURE

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality

(2008) S. Frantz et al.   EUROPEAN JOURNAL OF HEART FAILURE

Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure

(2008) Anca Radauceanu et al.   JOURNAL OF CARDIAC FAILURE

Cytokines and Myocardial Dysfunction: State of the Art

(2008) Ayman A. El-Menyar   JOURNAL OF CARDIAC FAILURE

Inflammatory pathways in patients with heart failure and preserved ejection fraction

(2007) Margit Niethammer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY